5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-phenylthiophene-2-carboxamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-N-phenylthiophene-2-carboxamide
• 英文别名: 5-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-phenylthiophene-2-carboxamide
• 化学式: C₁₉H₁₅NO₃S
• 分子量: 337.399
• InChiKey: NJEFVMADRWTANS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  75.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：AUTOPHAGYSCIENCES INC.

  公开号：US20180244644A1

  公开（公告）日：2018-08-30

  The present invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.

  本发明涉及化学式1所代表的化合物或其药用可接受的盐。根据本发明的化合物可用于预防或治疗与自噬相关的疾病。
• NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  申请人：Autophagysciences, Inc

  公开号：EP3339299A2

  公开（公告）日：2018-06-27

  The present invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.

  本发明涉及一种由化学式 1 表示的化合物或其药学上可接受的盐。根据本发明的化合物可用于预防或治疗自噬相关疾病。
• Catechol derivative and pharmaceutical composition comprising the same
  申请人：AUTOPHAGYSCIENCES INC.

  公开号：US10662169B2

  公开（公告）日：2020-05-26

  The present invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.

  本发明涉及一种由化学式 1 表示的化合物或其药学上可接受的盐。根据本发明的化合物可用于预防或治疗自噬相关疾病。
• METHOD FOR TREATING LIVER DISEASE BY ADMINISTERING PHARMACEUTICAL COMPOSITION COMPRISING CATECHOL DERIVATIVE
  申请人：AUTOPHAGYSCIENCES INC.

  公开号：US20200255397A1

  公开（公告）日：2020-08-13

  The present invention relates to a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of autophagy-related diseases.
• [EN] NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME<br/>[FR] NOUVEAU DÉRIVÉ DE CATÉCHOL ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT<br/>[KO] 신규한 카테콜 유도체 및 이를 포함하는 약학적 조성물
  申请人：YOO YOUNG PHARM CO LTD

  公开号：WO2017034242A2

  公开（公告）日：2017-03-02

  본 발명은 화학식 1로 표시되는 화합물, 또는 이의 약학적으로 허용가능한 염에 관한 것으로, 본 발명에 따른 화합물은 아토파지 (autophagy) 관련 질환의 예방 또는 치료에 유용하게 사용할 수 있다.